|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,198.85 INR | -0.10% |
|
+0.20% | -11.01% |
EPS & Dividend: GlaxoSmithKline Pharmaceuticals Limited
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 30 | 32 | 32 | 42 | 57 | 29.5 | 29.5 |
| Rate of return | 1.8% | 2.42% | 1.65% | 1.46% | 2.5% | 1.34% | 1.34% |
| EPS 2 | 100 | 36.05 | 34.83 | 54.76 | 61.15 | 67.3 | 75.97 |
| Distribution rate | 30% | 88.8% | 91.9% | 76.7% | 93.2% | 43.8% | 38.8% |
| Reference price 2 | 1,662.95 | 1,324.15 | 1,943.10 | 2,877.30 | 2,283.40 | 2,198.85 | 2,198.85 |
| Nbr of stocks (in thousands) | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | - |
| Announcement Date | 5/16/22 | 5/17/23 | 5/17/24 | 5/13/25 | 5/13/26 | - | - |
1INR in Million2INR
Estimates
Past dividends: GlaxoSmithKline Pharmaceuticals Limited
| 2026-05-29 | Ex-dividend date - 57 INR | 00:00 |
Upcoming Events: GlaxoSmithKline Pharmaceuticals Limited
| 2026-06-30 | Présentation aux Actionnaires / Analystes | 01:30 | |
| 2026-06-30 | Annual General Meeting | 01:30 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.34% | 1.34% | 32.71x | 14.02x | - | |
| 0.61% | 0.67% | 32.85x | 19.6x | 11.94x | |
| 2.27% | 2.37% | 25.13x | 6.33x | 5.79x | |
| 3.09% | 3.25% | 27.6x | -809.84x | 6.65x | |
| 3.09% | 3.17% | 17.38x | 6.41x | 4.29x | |
| 2.97% | 3.05% | 20.88x | 6.26x | 5.41x | |
| 1.87% | 1.98% | 22.34x | 5.2x | 4.67x | |
| 4.05% | 3.88% | 12.39x | 5.42x | 4.65x | |
| 2.9% | 3.06% | 22.62x | 16.86x | 6.06x | |
| 2.55% | 2.61% | -45.59x | 8.64x | 5.5x | |
| Average | 2.47% | 2.54% | 16.83x | -72.11x | 6.11x | |
| Weighted average by Cap. | 2.12% | 2.2% | 22.22x | -84.07x | 7.38x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
